Ariane Morel

2.5k total citations
10 papers, 194 citations indexed

About

Ariane Morel is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Ariane Morel has authored 10 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Ariane Morel's work include Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (4 papers) and Adenosine and Purinergic Signaling (2 papers). Ariane Morel is often cited by papers focused on Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (4 papers) and Adenosine and Purinergic Signaling (2 papers). Ariane Morel collaborates with scholars based in France, United States and Germany. Ariane Morel's co-authors include Yannis Morel, Éric Vivier, Pascale André, Luciana Batista, Marie‐Laure Thibult, Olivier Demaria, Frédéric Vely, Julien Carvelli, Nicolas Gourdin and Laurent Gauthier and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Biotechnology and Cancer Research.

In The Last Decade

Ariane Morel

9 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariane Morel France 6 113 84 57 28 26 10 194
Lingshuang Sheng China 7 51 0.5× 123 1.5× 45 0.8× 15 0.5× 39 1.5× 12 189
Hoyoung Lee South Korea 7 145 1.3× 68 0.8× 30 0.5× 12 0.4× 20 0.8× 10 199
Marine Villard France 7 86 0.8× 27 0.3× 29 0.5× 9 0.3× 31 1.2× 16 166
Donald Bastin Canada 8 171 1.5× 159 1.9× 86 1.5× 39 1.4× 67 2.6× 16 332
Elena Winheim Germany 5 112 1.0× 32 0.4× 42 0.7× 18 0.6× 51 2.0× 9 186
Dimitrios Patseas Greece 6 83 0.7× 22 0.3× 84 1.5× 20 0.7× 65 2.5× 10 224
Rémi Pescarmona France 6 57 0.5× 13 0.2× 51 0.9× 16 0.6× 29 1.1× 11 142
Dan Fu Ruan United States 4 179 1.6× 140 1.7× 19 0.3× 8 0.3× 30 1.2× 5 229
Ang Wei China 10 154 1.4× 61 0.7× 121 2.1× 7 0.3× 17 0.7× 38 275

Countries citing papers authored by Ariane Morel

Since Specialization
Citations

This map shows the geographic impact of Ariane Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariane Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariane Morel more than expected).

Fields of papers citing papers by Ariane Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariane Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariane Morel. The network helps show where Ariane Morel may publish in the future.

Co-authorship network of co-authors of Ariane Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Ariane Morel. A scholar is included among the top collaborators of Ariane Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariane Morel. Ariane Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gauthier, Laurent, Angéla Virone-Oddos, Jochen Beninga, et al.. (2023). Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123. Nature Biotechnology. 41(9). 1296–1306. 62 indexed citations
2.
Demaria, Olivier, Guillaume Habif, Marianna Müller, et al.. (2023). S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS. HemaSphere. 7(S3). e1234532–e1234532.
3.
Gauthier, Laurent, Angéla Virone-Oddos, Jochen Beninga, et al.. (2021). 852 Trifunctional NKp46/CD16a-NK cell engager targeting CD123 overcomes acute myeloid leukemia resistance to ADCC. SHILAP Revista de lepidopterología. A893–A893. 2 indexed citations
4.
Demaria, Olivier, Éric Vivier, Marie Vétizou, et al.. (2021). 851 Harnessing innate immunity in cancer therapies: the example of natural killer cell engagers. Regular and Young Investigator Award Abstracts. A892–A892. 5 indexed citations
5.
Magagna, Ilaria, Nicolas Gourdin, Yann Kieffer, et al.. (2021). CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer. Cancers. 13(23). 5878–5878. 28 indexed citations
6.
Demaria, Olivier, Julien Carvelli, Luciana Batista, et al.. (2020). Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19. Cellular and Molecular Immunology. 17(9). 995–997. 57 indexed citations
7.
Demaria, Olivier, Julien Carvelli, Joanna Fares, et al.. (2020). 483 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. SHILAP Revista de lepidopterología. A299.1–A299. 11 indexed citations
8.
Morel, Ariane, Cécile Bonnafous, Sylvia Trichard, et al.. (2016). Abstract 1491: IPH4301, an antibody targeting MICA and MICB exhibits potent cytotoxic activity and immunomodulatory properties for the treatment of cancer. Cancer Research. 76(14_Supplement). 1491–1491. 3 indexed citations
9.
Sicard, Hélène, Cécile Bonnafous, Ariane Morel, et al.. (2015). A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies. OncoImmunology. 4(9). e1022306–e1022306. 18 indexed citations
10.
Morel, Ariane, et al.. (2007). Angine streptococcique aux urgences pédiatriques: performances et impact d'un test de diagnostic rapide. Archives de Pédiatrie. 14(9). 1057–1061. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lingshuang Sheng Breakdown of academic impact, for papers by Hoyoung Lee Breakdown of academic impact, for papers by Marine Villard Breakdown of academic impact, for papers by Donald Bastin Breakdown of academic impact, for papers by Elena Winheim Breakdown of academic impact, for papers by Dimitrios Patseas Breakdown of academic impact, for papers by Rémi Pescarmona Breakdown of academic impact, for papers by Dan Fu Ruan Breakdown of academic impact, for papers by Ang Wei
Rankless by CCL
2026